BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9213774)

  • 1. Residual clones in childhood leukemia.
    Dibenedetto SP; Schilirò G
    N Engl J Med; 1997 Jul; 337(1):50; author reply 51. PubMed ID: 9213774
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
    von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden VH; van Dongen JJ; Harbott J; Panzer-Grümayer ER; Schrappe M; Rascher W; Metzler M
    Leuk Res; 2009 Aug; 33(8):1082-8. PubMed ID: 19081626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
    Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
    Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead.
    Sandoval C
    Leuk Res; 2010 Apr; 34(4):418-9. PubMed ID: 19892401
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
    Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
    Sedlácek P; Trka J; Zuna J; Hrusák O; Honzátková-Krsková L; Stary J
    Haematologica; 2000 Oct; 85(10):1100-2. PubMed ID: 11025608
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of molecular screening in childhood lymphoblastic leukemias].
    Anguita E; González FA; Contra T; Martín N; Valverde F; Villegas A
    Sangre (Barc); 1998 Feb; 43(1):7-11. PubMed ID: 9577176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL.
    Fronkova E; Madzo J; Zuna J; Reznickova L; Muzikova K; Hrusak O; Stary J; Trka J
    Leukemia; 2005 Jul; 19(7):1296-7. PubMed ID: 15858617
    [No Abstract]   [Full Text] [Related]  

  • 13. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual clones in childhood leukemia.
    Loscalzo CP
    N Engl J Med; 1997 Jul; 337(1):50; author reply 51. PubMed ID: 9213775
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia.
    Fears S; Vignon C; Bohlander SK; Smith S; Rowley JD; Nucifora G
    Genes Chromosomes Cancer; 1996 Oct; 17(2):127-35. PubMed ID: 8913730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method.
    Chen IM; Chakerian A; Devidas M; Borowitz MJ; Hunger SP; Willman CL; Viswanatha DS
    Br J Haematol; 2006 Nov; 135(3):358-61. PubMed ID: 16984387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia.
    Liang DC; Shih LY; Yang CP; Hung IJ; Chen SH; Jaing TH; Liu HC; Chang WH
    Med Pediatr Oncol; 2002 Jul; 39(1):12-7. PubMed ID: 12116073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
    Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
    N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular epidemiology of high-incidence cancers in Mexico].
    Berumen J; Miranda EI; Zafra G; Casas L; Segura E; Ordoñes RM; Aguirre J; Martínez M; Rosas A; Ibarra V; Pedraza L; Saad A; Marroquín A; Gutiérrez M; Martínez A; Gariglio P
    Gac Med Mex; 1997; 133 Suppl 1():35-41. PubMed ID: 9580106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.